Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Spano

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed update]Jean-Philippe Spano, Jacques-Olivier Bay
Cancer|October 19, 2011
Current and emerging targeted therapies for metastatic breast cancerEdith A Perez, Jean-Philippe Spano
Critical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony Gonçalves
Melanoma Research|November 4, 2010
Paving the way to the cure of melanomaRoger Mouawad, Jean-Philippe Spano, David Khayat
Bulletin Du Cancer|August 1, 2013
[Small HER2-positive breast cancer: which prognosis and which adjuvant treatment?]Anthony Gonçalves, Maria Vassilakopoulou, Jean-Philippe Spano
Bulletin Du Cancer|May 19, 2005
[Aromatase inhibitors in adjuvant setting in breast cancer]Jean-Philippe Spano, David Khayat, Thierry Delozier
Bulletin Du Cancer|January 3, 2006
EGFR/VEGF signalling pathway in colorectal cancer: the way we are!Jean-Philippe Spano, Gérard Milano, José Baselga
Medical Oncology (Northwood, London, England)|December 7, 2018
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH GroupAurelien Gobert, Jean-Philippe Spano, Jacques Cadranel
Bulletin Du Cancer|December 6, 2006
[Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor]Nicolas Mounier, Stéphane Vignot, Jean-Philippe Spano
Current HIV Research|February 19, 2010
Hodgkin lymphoma in HIV positive patientsNicolas Mounier, Michele Spina, Jean Philippe Spano
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed update]Jean-Philippe Spano, Jacques-Olivier Bay
Cancer|October 19, 2011
Current and emerging targeted therapies for metastatic breast cancerEdith A Perez, Jean-Philippe Spano
Critical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony Gonçalves
Melanoma Research|November 4, 2010
Paving the way to the cure of melanomaRoger Mouawad, Jean-Philippe Spano, David Khayat
Bulletin Du Cancer|August 1, 2013
[Small HER2-positive breast cancer: which prognosis and which adjuvant treatment?]Anthony Gonçalves, Maria Vassilakopoulou, Jean-Philippe Spano
Bulletin Du Cancer|May 19, 2005
[Aromatase inhibitors in adjuvant setting in breast cancer]Jean-Philippe Spano, David Khayat, Thierry Delozier
Bulletin Du Cancer|January 3, 2006
EGFR/VEGF signalling pathway in colorectal cancer: the way we are!Jean-Philippe Spano, Gérard Milano, José Baselga
Medical Oncology (Northwood, London, England)|December 7, 2018
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH GroupAurelien Gobert, Jean-Philippe Spano, Jacques Cadranel
Bulletin Du Cancer|December 6, 2006
[Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor]Nicolas Mounier, Stéphane Vignot, Jean-Philippe Spano
Current HIV Research|February 19, 2010
Hodgkin lymphoma in HIV positive patientsNicolas Mounier, Michele Spina, Jean Philippe Spano
Pageof 22